Henman MC - Search Results

1

Costs and trends in pancreatic cancer treatment.

O'Neill CB, Atoria CL, O'Reilly EM, LaFemina J, Henman MC, Elkin EB. O'Neill CB, et al. Among authors: henman mc. Cancer. 2012 Oct 15;118(20):5132-9. doi: 10.1002/cncr.27490. Epub 2012 Mar 13. Cancer. 2012. PMID: 22415469 Free PMC article.

2

Treatment complications and survival in advanced laryngeal cancer: a population-based analysis.

O'Neill CB, O'Neill JP, Atoria CL, Baxi SS, Henman MC, Ganly I, Elkin EB. O'Neill CB, et al. Among authors: henman mc. Laryngoscope. 2014 Dec;124(12):2707-13. doi: 10.1002/lary.24658. Epub 2014 Oct 4. Laryngoscope. 2014. PMID: 24577936 Free PMC article.

3

Treatment-related toxicities in older adults with head and neck cancer: A population-based analysis.

O'Neill CB, Baxi SS, Atoria CL, O'Neill JP, Henman MC, Sherman EJ, Lee NY, Pfister DG, Elkin EB. O'Neill CB, et al. Among authors: henman mc. Cancer. 2015 Jun 15;121(12):2083-9. doi: 10.1002/cncr.29262. Epub 2015 Feb 27. Cancer. 2015. PMID: 25728057 Free PMC article.

4

ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy.

O'Neill CB, Atoria CL, O'Reilly EM, Henman MC, Bach PB, Elkin EB, O'Neill CB, Atoria CL, O'Reilly EM, Henman MC, Bach PB, Elkin EB. O'Neill CB, et al. Among authors: henman mc. J Oncol Pract. 2016 Feb;12(2):151-2; e138-48. doi: 10.1200/JOP.2015.004812. J Oncol Pract. 2016. PMID: 26869655 Free PMC article.

5

Measuring drug burden in older adults with intellectual disabilities: Critical issues for consideration in finding the optimal measure to improve safety of medicines use.

O'Dwyer M, McCallion P, McCarron M, O'Connell J, Henman M. O'Dwyer M, et al. Expert Opin Drug Saf. 2020 Jun;19(6):649-652. doi: 10.1080/14740338.2020.1751119. Epub 2020 Apr 13. Expert Opin Drug Saf. 2020. PMID: 32241202

6

Laxative use among older adults with intellectual disability: a cross-sectional observational study.

AlMutairi H, O'Dwyer M, Burke E, McCarron M, McCallion P, Henman MC. AlMutairi H, et al. Among authors: henman mc. Int J Clin Pharm. 2020 Feb;42(1):89-99. doi: 10.1007/s11096-019-00942-z. Epub 2019 Dec 2. Int J Clin Pharm. 2020. PMID: 31792735

7

Introduction of a dose-banding system for parenteral chemotherapy on a haematology-oncology day ward.

O'Leary CE, Collins A, Henman MC, King F. O'Leary CE, et al. Among authors: henman mc. J Oncol Pharm Pract. 2019 Mar;25(2):351-361. doi: 10.1177/1078155217736376. Epub 2017 Oct 23. J Oncol Pharm Pract. 2019. PMID: 29059028

8

Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.

Grimes RT, Bennett K, Tilson L, Usher C, Smith SM, Henman MC. Grimes RT, et al. Among authors: henman mc. Br J Clin Pharmacol. 2015 Jun;79(6):1000-9. doi: 10.1111/bcp.12573. Br J Clin Pharmacol. 2015. PMID: 25521800 Free PMC article.

9

Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study.

O'Connell J, Burke É, Mulryan N, O'Dwyer C, Donegan C, McCallion P, McCarron M, Henman MC, O'Dwyer M. O'Connell J, et al. Among authors: henman mc. Br J Clin Pharmacol. 2018 Mar;84(3):553-567. doi: 10.1111/bcp.13479. Epub 2018 Jan 5. Br J Clin Pharmacol. 2018. PMID: 29193284 Free PMC article.

10

Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.

Grimes RT, Ensor J, Bennett K, Henman MC. Grimes RT, et al. Among authors: henman mc. Prim Care Diabetes. 2016 Aug;10(4):237-43. doi: 10.1016/j.pcd.2015.11.002. Epub 2015 Dec 1. Prim Care Diabetes. 2016. PMID: 26654852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters